"Even when medicines are funded off the lists - the time taken to achieve an investment decision has doubled over the past 2 years. (Is now an average of 7.7 years, compared to 3.4 years in 2020)," says the new report.
New report reveals blowout in wait times for funded access in NZ
April 27, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
TGA approves GSK's six‑monthly treatment for severe eosinophilic asthma and nasal polyps
July 28, 2026 - - Latest News -
Long-COVID still reshaping life for medically vulnerable Australians
July 28, 2026 - - Latest News -
Australians with rare diseases still waiting too long for access to treatments
July 28, 2026 - - Latest News -
New research shows chronic pain is widespread and undertreated in Australia
July 28, 2026 - - Latest News -
Bellberry announces new appointment to board of directors
July 27, 2026 - - Latest News -
The power of this commitment might be as a comparison of national intent
July 27, 2026 - - Latest News -
New AI platform aims to give patients a strong voice in medicines funding
July 27, 2026 - - Latest News

